NFOCUS NEUROMEDICAL
Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical, Inc. operates as a subsidiary of Covidien plc.
NFOCUS NEUROMEDICAL
Industry:
Hardware Health Care Software
Founded:
1997-01-01
Address:
Palo Alto, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
20.3 M USD
Similar Organizations
Nexalin Technology
Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.
WellApps
WellApps develops and distributes symptom tracking applications for patients with chronic illnesses.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-03-08 | StarFire Medical | StarFire Medical acquired by Nfocus Neuromedical | N/A |
| 2007-04-03 | Acta Vascular Systems | Acta Vascular Systems acquired by Nfocus Neuromedical | N/A |
Investors List
Endeavour Vision
Endeavour Vision investment in Series C - Nfocus Neuromedical
Technology Partners
Technology Partners investment in Series B - Nfocus Neuromedical
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Nfocus Neuromedical
More informations about "Nfocus Neuromedical"
Nfocus Neuromedical - Crunchbase Company Profile
Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat …See details»
Nfocus Neuromedical Company Profile 2024: Valuation, …
Developer of medical devices intended to treat brain aneurysms. The company develops a single-deployment, easy-to-use embolization device that blocks blood flow while providing a scaffold …See details»
Nfocus Neuromedical - Funding, Financials, Valuation
Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms.See details»
nFocus Neuromedical - VentureRadar
Nfocus Neuromedical’s product LUNAâ„¢ has been designed to treat brain aneurysms, providing physicians with a single-deployment, easy-to-use... ... Find out more about nFocus …See details»
nFocus Neuromedical - Products, Competitors, Financials, …
Nfocus is a neurovascular development, manufacturing and marketing company focused on treating hemorrhagic stroke. Current and future product programs are aimed at rapid treatment …See details»
Nfocus Neuromedical Inc - Company Profile and News
Nfocus Neuromedical, Inc. develops and manufactures medical devices. The Company offers products such as neurovascular devices for the treatment of neurovascular aneurysms. …See details»
Covidien Acquires Nfocus Neuromedical | Mergr M&A Deal …
Nfocus Neuromedical, Inc. is a neurovascular development, manufacturing and marketing company focused on treating hemorrhagic stroke.See details»
Covidien acquires Nfocus Neuromedical - 2013-02-19
Feb 19, 2013 · Nfocus Neuromedical Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms. Acquiring Organization: Covidien Global …See details»
nFocus Neuromedical Stock Price, Funding, Valuation, …
Jul 22, 2010 · See nFocus Neuromedical funding rounds, investors, investments, exits and more. Evaluate their financials based on nFocus Neuromedical's post-money valuation and revenue.See details»
CardioVasc Acquires Acta Vascular Systems, Becomes …
Apr 4, 2007 · The new combined entity will be called Nfocus Neuromedical, Inc. Nfocus combines the pioneering aneurysm treatment technology of CardioVasc with the established detachable …See details»
Nfocus Neuromedical Inc. Raises Over $20 Million in …
Apr 4, 2007 · MENLO PARK, Calif., April 3 /PRNewswire/ -- Nfocus Neuromedical Inc. today announced that it has completed $20.3 million Series B private equity financing. Funds will be …See details»
Nfocus Neuromedical - Updates, News, Events, Signals
Feb 19, 2013 · Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms.See details»
Nfocus Neuromedical Announces FDA 510(k) Clearance …
Jan 12, 2011 · Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, today announced that the company …See details»
Nfocus Neuromedical, Inc. Announces Positive One-Year …
PALO ALTO, Calif., July 25, 2012 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, …See details»
Nfocus Neuromedical, Inc. Announces Positive One-Year …
Jul 26, 2012 · Nfocus is developing the next generation treatment for brain aneurysms. The company’s innovative LUNA product is a single-deployment, easy-to-use embolization device …See details»
Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization …
Feb 15, 2011 · About Nfocus Neuromedical, Inc. Nfocus is developing the next generation treatment for brain aneurysms. The company's innovative LUNA â„¢ product is a single …See details»
Nfocus Neuromedical - Contacts, Employees, Board …
Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms.See details»
Nfocus Neuromedical - Tech Stack, Apps, Patents
Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms.See details»
Nfocus Neuromedical Announces FDA 510(k) Clearance …
Jan 11, 2011 · The Acta VOS provides physicians with a minimally-invasive alternative to current treatment options for an array of common and potentially serious vascular lesions. The Acta …See details»
Nfocus Neuromedical, Inc. Announces Positive One-Year …
Jul 25, 2012 · Nfocus is developing the next generation treatment for brain aneurysms. The company's innovative LUNA â„¢ product is a single-deployment, easy-to-use embolization …See details»